Related Experiment Video
Updated: Jun 28, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Cohort profile: Swiss personalized health network cohort consortium
Murielle Bochud1, Samuel El Bouzaïdi Tiali2, Jan Armida3
1Unisanté, University Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland. murielle.bochud@unisante.ch.
None:
Swiss cohort studies provide high-quality longitudinal data, but finding and comparing relevant studies across cohorts has historically been challenging. The Swiss Personalized Health Network Cohort Consortium (SPHN-CC) was established to address these limitations by creating the first coordinated network of Swiss cohort studies within the internationally recognized Maelstrom Research catalogue. Participating cohorts were invited in 2021-2022, including longitudinal and cross-sectional studies with 1010-21,993 participants. Data collected include questionnaires, physical and cognitive assessments, administrative records, and biological samples. Variables were classified into 18 domains and 134 subdomains, and an online metadata catalogue was implemented to document study designs, explore variable content, and assess harmonization potential. The catalogue enables researchers to identify study-specific and harmonized variables for co-analysis. Core variables, such as age, sex/gender, anthropometrics, and medication use, are widely available, while other variables vary across cohorts. Harmonization assessments demonstrate that several key variables can be co-analyzed across multiple studies, supporting collaborative research with over 37,000 participants. A use case illustrates the potential for harmonizing and co-analyzing data across studies. The SPHN-CC strengthens Swiss cohort research by enhancing data discoverability, supporting harmonization, and facilitating cross-cohort and international research, providing a model for more efficient use of high-value longitudinal data.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bioavailability Study Design: Healthy Subjects Versus Patients
Integrated Healthcare System
